Start with the evidence.
New to peptides? Start here. Learn what a peptide is, what a study can tell you, and where the answers are still uncertain.
01 · Begin with the molecule
Understand what a peptide is
A peptide is a short chain of amino acids, the building blocks that also make up proteins. Some peptides carry signals in the body. What a peptide does depends on the exact substance and product, how it enters the body (its route), and how it is used. An explanation of how it might work is called a mechanism. That explanation alone does not show that it helps people.
02 · Sort the evidence
Keep four kinds separate
- Product approval: an official drug label says which product and uses were approved, and describes known risks.
- Human research: studies report what happened in a particular group of people.
- Animal and lab research: early findings help researchers decide what to test in people.
- Community reports: people describe their experiences online. These reports cannot establish whether a product caused a benefit or harm.
Research, product approval and personal reports answer different questions. Keep them separate as you read.
How the evidence labels work03 · Read the outcome
Ask what was measured
Start with four questions: What changed? How many people took part? How long did the study last? What was the treatment compared with? The change being measured is the outcome. A comparison group helps researchers judge whether the treatment made a difference.
Then check which harms were tracked and whether the study used the same product, route and purpose you are reading about. An average result does not describe what happened to every person. A result in one group may not apply to another.
04 · Mark the gaps
Keep unknowns visible
For many peptides, there is little or no research in people. The U.S. Food and Drug Administration (FDA) may also identify missing safety data or concerns about unwanted substances in a product (impurities). Animal results, a seller’s purity claim and personal stories do not fill those gaps.
An adverse event is an unwanted health event reported after using a product. The FDA cautions that these reports are unverified: a report alone cannot show that the product caused the event or how often it occurs.
05 · Take questions to care
Talk with a clinician
Ask a clinician: Is there an approved medicine for this condition? What benefits and harms have been studied? Could it affect other medicines I take? Does the evidence cover this exact product and use?
Approval applies to a specific product and the uses described in its official label. It does not transfer to a research vial or another use.
06 · Follow the source
Check the original record
ClinicalTrials.gov is a public register of studies. Being listed there does not mean a treatment worked or received FDA approval. Check whether the study is still running, what it tested and whether results were published. Even a completed study may have no results posted.
Open the primary referencesPrimary sources
These official references were checked on 1 October 2026. Each link supports the scope described below; source pages can change.
- U.S. Food and Drug Administration: Development & Approval ProcessExplains preclinical and human testing, approval for an intended use, risk-benefit review, and post-market monitoring.
- U.S. Food and Drug Administration: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksSubstance-specific concerns and data gaps for certain ingredients proposed for compounding; not a finding about every product or route.
- ClinicalTrials.gov, U.S. National Library of Medicine: Common QuestionsStudy records are supplied by sponsors or investigators; records may be ongoing, completed, stopped, or have no posted results.
- World Anti-Doping Agency: 2026 Prohibited ListThe list effective January 1, 2026; includes BPC-157 in S0 and examples of growth-hormone releasing peptides in S2.
- U.S. Food and Drug Administration: FDA Adverse Event Monitoring System: Data LimitationsReports are unverified observations; a report does not establish causation or event rates.
- U.S. Food and Drug Administration: Dosing Errors Associated with Compounded Injectable Semaglutide ProductsFDA’s reports on dose-measurement errors and hospitalizations concern compounded semaglutide vials; they are not evidence about every peptide.
Safety basicsCompare peptide profilesBrowse the full source library